The Leukapheresis Products Market has driven prominent changes in the recent past, presenting the healthcare industry as a dynamic sector that appreciates the growing need for advanced therapeutic approaches. Leukapheresis, a technique concerned with the separation of white blood cells from blood, is a powerfull therapeutic tool for treating blood diseases like leukemia and lymphoma. The leukapheresis products market has been influenced by several milestone factors in the industry, dictating its direction.
Another major pattern is that of blood diseases, mostly leukemia occurring more often. Such as with a growing number of people having been diagnosed with these diseases worldwide, the need for reliable and advanced leukapheresis devices has skyrocketed. Increased perception and timely hematology disorders detection has significantly pushed the market's boundaries, and companies have been forced to innovate and develop advanced products to meet ever-growing healthcare needs.
Technological advances represent a key factor to the evolution of the leukaphersis product markets. Advancements in research and development have resulted into new innovative technologies, for instance the automatic leukapheresis systems. The use of these advanced systems, which provide good precision, shorter procedural times and improved safety, makes them the most favored complex medical facilities among healthcare professionals. The market is marked by the gradual move from automatized systems which manifests the industry's dedication in delivering excellent therapeutic solutions.
The worldwide healthcare industry has been experiencing that increasing personalized medicine has also touched upon the segment of the leukapheresis products market. Consequently with providers of healthcare and investigative researchers making a big effort to personalize treatments to an individual patient profile, the need for leukapheresis products that help separate specified cell populations has grown. Through this individualized method of treatment not only targeted drug for effectiveness but also with limited side effects leading to the adoption of specialized leukapheresis products.
Moreover, market has some of pharmaceutical companies been collaborating and partnership with research centers and manufacturers of leukapheresis devices. These partnerships aim to speed up the time needed for innovation and approvals, making the whole process smoother. Indeed, these cooperations usually promote the appearance of the most innovative technologies and therapies playing a crucial part in the development of leukapheresis products.
Cheapness with regard to prices and the availability contribute heavily towards making up the market. Attempts to make leukapheresis cheaper and easier to reach a larger patient category resulted in advanced and affordable disposables and devices. Companies are now seeking to produce items that not only exceed quality standards but also are of an affordable nature, thereby permitting the wide-ranging application of the leukapheresis product across more people.
Segmentation:
The leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.
The market, on the basis of application, has been segmented into research applications and therapeutic applications.
On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The leukapheresis products market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European leukapheresis products market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.Â
The leukapheresis products market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The leukapheresis products market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players:
Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, StemExpress and others are some of the key players in the leukapheresis products market.
Regional Market Summary: Global Leukapheresis Products Market Share (%), by Region, 2017
Source: America’s Blood Centers, White Papers, Company Presentations, Annual Reports
Geographically, the Americas is anticipated to dominate the leukapheresis products market owing to the growing number of blood donations, rising incidence and prevalence of leukaemia and growing demand for leukopaks in clinical research. According to the America’s Blood Centers, more than 15 million pints of blood are transfused in the US each year.
Europe is expected to hold the second largest position in the leukapheresis products market. The market growth in this region is attributed to the increasing prevalence of leukemia and well-developed healthcare sector in the region. According to the Cancer Research UK, about 9,900 new cases of leukaemia were reported in UK in 2015.
The leukapheresis products market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major multinational pharma and biotech companies, and improvement in healthcare access.
The Middle East & Africa has the lowest share of the leukapheresis products market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Recent Development
Leukapheresis Products Market, by Type
Leukapheresis Products Market, by Application
Leukapheresis Products Market, by End User
Leukapheresis Products Market, by Region
Leukapheresis Products Market, by Key Players
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)